Intra-hospital pharmacovigilance. Knowledge and practices

Authors

Keywords:

pharmacovigilance, adverse drug reactions, health knowledge, attitudes, practice

Abstract

Introduction: pharmacovigilance is the discipline that deals with the collection, follow-up, investigation, assessment and evaluation of information from health professionals and patients on adverse drug reactions; incomplete knowledge of this discipline is currently one of the greatest weaknesses of modern therapeutics.
Objective: to evaluate knowledge and practices of Pharmacovigilance in medical personnel working at the "Enrique Cabrera" Hospital in Havana about the most commonly used drugs in patients with cardiovascular diseases and the most frequent comorbidities.
Methods: a cross-sectional descriptive study was carried out, the universe consisted of 410 physicians and the sample consisted of 80 of them chosen at random. Data were collected through the application of an anonymous questionnaire.
Results: Specialists represented 81.25% and physicians without teaching category 70%. There was a predominance of respondents with inadequate knowledge about the concept of Pharmacovigilance (70%) and its importance (55%); there was an adequate level of knowledge about the drugs that are appropriately prescribed according to the most frequent diseases and there was an inadequate identification of the drugs causing rhythm disorders (70%).
Conclusions: a large percentage of the staff has a deficient knowledge of pharmacovigilance due to lack of knowledge of its generalities, but not in relation to adverse drug reactions. There is a deficiency in the knowledge of the drugs most used in daily medical practice and which cause rhythm disorders. Intervention measures are required to reverse this situation.

Downloads

Download data is not yet available.

Author Biographies

Yanitsy Chipi Rodríguez, Hospital General Docente Enrique Cabrera Cossío

Especialista de I Grado en Medicina General Integral. Especialista de I Grado en Cardiología. Profesora Instructora.

Taimara Pérez Rivera, Hospital General Docente Enrique Cabrera Cossío

Especialista de I Grado en Medicina General Integral. Especialista de I Grado en Cardiología. Máster en Farmacoepidemiología. Profesora Auxiliar.

Ana Julia García Milián, Corporación de Salud del Maresme y la Selva

Especialista de I y II Grado en Farmacología. Máster en Economía en Salud. Profesora Auxiliar, Investigadora Auxiliar.

Liliam Gretel Cisneros Sánchez, Hospital General Docente Enrique Cabrera Cossío

Especialista de I Grado en Medicina General Integral. Especialista de I Grado en Cardiología. Máster en Urgencias Médicas. Profesora Asistente.

Annia María Carrero Vázquez, Hospital General Docente Enrique Cabrera Cossío

Especialista de I Grado en Medicina General Integral. Especialista de I Grado en Cardiología. Máster en Urgencias Médicas. Profesora Auxiliar.

Geovedys Martínez García, Hospital General Docente Enrique Cabrera Cossío

Especialista de I y II Grado en Cardiología. Máster en Urgencias Médicas. Profesor Auxiliar.

References

1.Mata Maldonado J, Ortiz Reynoso M, Islas Flores H, Díaz Flores M, De León Camacho V, Tenorio Vieyra LE. Impacto de una intervención educativa en los conocimientos en farmacovigilancia y en el reporte de reacciones adversas a los medicamentos de profesionales de la salud en un hospital público de segundo nivel de atención en el Estado de México, México. Rev Mex Cienc Farm [Internet]. 2017 [citado 16/02/2021]; 48(4):78-89. Disponible en: https://www.redalyc.org/pdf/579/57956617009.pdf

2.Organización Mundial de la Salud. Promoción del uso racional de medicamentos: componentes centrales [Internet]. Ginebra: OMS; 2002 [citado 16/02/2021]. Disponible en: https://apps.who.int/iris/bitstream/handle

/10665/67532/WHO_EDM_2002.3_spa.pdf

3.Tarragó Portelles SS, Gravier Hernández R, Gil del Valle L. La Farmacovigilancia en Cuba y la Infranotificaciones de Reacciones Adversas a los Medicamentos. Horiz Sanitario [Internet]. 2019 [citado 16/02/2021];18(1):7-15. Diponible en: https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2007-74592019000100007. https://doi.org/10.19136/hs.a18n1.2514

4.Rodríguez Betancourt L, García Vigil JL, Giral Barnés C, Hernández Santillán D, JassoGutiérrez L. Farmacovigilancia I. El inicio. Rev Med IMSS [Internet]. 2004 [citado 16/02/2021];42(4):327-329. Disponible en: https://www.medigraphic.com/pdfs/imss/im-2004/im044h.pdf

5.FuronesMourelle J, Péperz Peña J. Necesidad de la Farmacoepidemiología. En: Furones Mourelle J, Bastanzuri Lara C, Calvo Barbado DM, Jimenez López G, Péperz Peña J, Cruz Barrios DA. Farmacoepidemiología. Uso racional de medicamentos. La Habana: Editorial Academia; 2010. p. 1-14.

6.Rodríguez Duque R, Gómez Leyva B, Rodríguez Moldón Y, Díaz Armas MT. Las reacciones adversas como causa de hospitalización. CCM [Internet]. 2019 [citado 16/02/2021];23(1):168-188. Disponible en: https://revcocmed.sld.cu/index.php/cocmed/article/view/2913/1366

7.Alfonso Orta I, Hevia Pumariega R, Jiménez López G, Ramón Fabregas L, Hernández Mullings AO, Barbán Lores D, et al. Curso Básico de Farmacovigilancia orientado a la industria, desde el ámbito regulador. La Habana: Cecmed; 2017 [citado 16/02/2021]. Disponible en: https://www.cecmed.cu/file/2608/download?token=VM7_rhLK

8.Centro para el desarrollo de la farmacoepidemiología. Formulario Nacional de Medicamentos. 4ta ed. La Habana: ECIMED; 2014 [citado 16/02/2021]. Disponible en: http://www.ecimed.sld.cu/2014/10/08/1943/

9.Castillo Torres ML. Conocimiento de farmacovigilancia y reporte de reacciones adversas institucional [tesis]. Poza Rica, Veracruz: Universidad Veracruzana; 2014 [citado 16/02/2021]. Disponible en: https://www.uv.mx/blogs/favem2014/files/2014/06/Tesis-Monse.pdf

10.Suazo Jarquín CA, Sobalvarro Coronado AC, Guevara Altamirano CA. Conocimientos acerca del uso racional de fármacos de interés odontológico por estudiantes de 4to año, de la Facultad de Odontología UNAN-LEÓN, primer semestre, 2017 [tesis]. León: Universidad Nacional Autónoma de Nicaragua [citado 16/02/2021]. Disponible en: https://repositoriosiidca.csuca.org/Record/RepoUNANL6908

11.Ruiz Hernández A, Cruz Barrios MA, Furones Mourelle JA, Palenzuela Rodríguez I. Conocimientos sobre farmacovigilancia del personal de estomatología en municipios seleccionados. Medimay [Internet]. 2015 [citado 16/02/2021];21(3):575-584. Disponible en: https://revcmhabana.sld.cu/index.php/rcmh/article/view/863/1287

Downloads

Published

2023-07-24

How to Cite

1.
Chipi Rodríguez Y, Pérez Rivera T, García Milián AJ, Cisneros Sánchez LG, Carrero Vázquez AM, Martínez García G. Intra-hospital pharmacovigilance. Knowledge and practices. Acta Méd Centro [Internet]. 2023 Jul. 24 [cited 2025 Jun. 29];17(3). Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/1761

Issue

Vol. 17 No. 3 (2023): Julio-Septiembre

Section

Original Articles

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).